Achieve Life Sciences (ACHV) filed a prospectus relating to the resale by selling shareholders, from time to time, of up to 49.42M shares of common stock.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHV:
- Achieve Life Sciences Adds Director Amid Board Transitions
- Achieve Life Sciences reports Q1 EPS (19c), consensus (30c)
- Options Volatility and Implied Earnings Moves Today, May 12, 2026
- ACHV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- CrowdStrike, ADMA, Achieve, AbbVie, Valero Trending With Analysts